Exin Therapeutics enables AI agents to perform brain surgery for epilepsy treatment in mice.
Biotech startup Exin Therapeutics claims it has enabled an AI agent to perform brain surgery for epilepsy treatment in mice. CEO Gabriel Ocana-Santero shared the process on X.
Return to original text
A short introduction is retained here; the full text from the source website is not reposted. For specific wording and subsequent updates, please refer to the original article.
Open AIHOT original